Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity in Oncology Patients

NCT07564479 is registered in ClinicalTrials.gov with Minia University as lead sponsor.

NCT NCT07564479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity in Oncology Patients
Lead sponsor
Minia University
Phase
Phase 2
Overall status
Recruiting
Start date
March 10, 2026
Completion date
June 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin nephrotoxicity, nephrotoxicity